Jan 13 (Reuters) - U.S. drugmaker Pfizer ( PFE ) is going all in to develop its experimental obesity drug and has been recruiting more experts in that area, Chief Exeuctive Officer Albert Bourla said at the JPMorgan Healthcare conference on Monday. ...

(Reuters) -U.S. drugmaker Pfizer ( PFE ) is going all in to develop its experimental obesity drug and has been recruiting more experts in that area, Chief Exeuctive Officer Albert Bourla said at the JPMorgan Healthcare Conference on Monday. We are all in ... we are building our teams ... We are recruiting experts in obesity over the last, let's...

01:44 PM EST, 01/13/2025 (MT Newswires) -- Tech stocks declined Monday afternoon with the Technology Select Sector SPDR Fund (XLK) falling 1.1% and the SPDR S&P Semiconductor ETF (XSD) dropping 1.4%. The Philadelphia Semiconductor index shed 0.8%. In corporate news, Clearwater Analytics ( CWAN ) agreed to buy Enfusion ( ENFN ) for $1.5 billion in cash and stock. Enfusion...

Deep-pocketed investors have adopted a bearish approach towards McDonald's , and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in MCD usually suggests something big is about to happen. We gleaned this information from our observations today...